GRK5 Controls SAP97-Dependent Cardiotoxic β1 Adrenergic Receptor-CaMKII Signaling in Heart Failure

Bing Xu1,2, Minghui Li2,3, Ying Wang2

  • 1From the VA Northern California Health Care System, Mather, CA (B.X., Y.K.X.).

Insights

The scaffold protein SAP97 is crucial for maintaining cardiac β1AR signaling integrity. Its loss exacerbates heart failure by promoting detrimental CaMKII signaling pathways.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Signal Transduction

Background:

  • Cardiotoxic β1 adrenergic receptor (β1AR) signaling, involving CaMKII, is critical in heart failure development.
  • SAP97 (synapse-associated protein 97) is a scaffold protein that organizes the β1AR signalosome.

Purpose of the Study:

  • To elucidate the dynamics of the β1AR-SAP97 signalosome.
  • To investigate the role of this complex in chronic cardiotoxic signaling contributing to heart failure.

Main Methods:

  • Examined the integrity of the cardiac β1AR-SAP97 complex in heart failure models.
  • Generated cardiac-specific SAP97 deletion in mice to study β1AR signaling.
  • Investigated effects of aging, adrenergic stimulation, and pressure overload.

Main Results:

  • Reduced β1AR-SAP97 complex integrity in heart failure.
  • Cardiac SAP97 deletion caused cardiomyopathy and exacerbated cardiac dysfunction.
  • Loss of SAP97 promoted PKA- and Epac-dependent CaMKII activation, driving detrimental remodeling.
  • GRK5 (G-protein receptor kinase-5) mediates SAP97 dissociation from β1AR.

Conclusions:

  • SAP97 is critical for maintaining cardiac β1AR signaling integrity.
  • A detrimental cardiac GRK5-CaMKII axis contributes to heart failure.
  • This axis presents a potential therapeutic target for heart failure.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
796
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.7K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
664
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
575